socalTECH

NOVEMBER 22, 2013

San Diego-based Avalon Ventures announced this morning that it has launched a new company, Sitari Pharmaceuticals , with $10M in a Series A financing. disease celiac lifescience biotech capital venture glaxosmithkline pharmaceuticals sitary ventures avalong' READ MORE>>.

Avalon 153

Avalon San Diego Capital Funding 153

socalTECH

SEPTEMBER 27, 2016

The funding was led by Avalon Ventures and also included Bregua Corporation, Lilly Asia Ventures, Osage University Partners, and Vivo Capital. The startup, based in the COI Pharmaceuticals cluster of companies in San Diego, is based on research developed by Bin Liu, Ph.D., READ MORE>>.

Avalon 100

Avalon San Diego Research Capital 100

socalTECH

DECEMBER 4, 2015

The funding was led by Avalon Ventures and TPG Biotech, and also included Correlation Ventures and Osage University Partners. The startup said it is developing novel drugs based on the anti-cancer activity of metformin and designed to reduce cancer energy production to treat a range of cancer types.

UCLA 100

UCLA Avalon San Diego Los Angeles 100

Xconomy

AUGUST 17, 2016

and San Diego’s Avalon Ventures. Inbio Ventures, a venture capital management company, represented Pharmstandard in the deal. Avelas plans to use the new funding to advance development of AVB-620, the company’s lead diagnostic agent, for use in breast cancer surgeries, CEO Carmine Stengone told me yesterday.

Avalon 40

Avalon San Diego Study Invest 40

Xconomy

JULY 20, 2016

First came Inception Sciences , a holding company for spinning out biotech startups established by Versant Ventures and Peppi Prasit, the veteran San Diego drug developer. It’s a little like what Avalon is doing. We really have a development focus,” Martin told me. “We We are taking capital as needed, not sooner.”.

San Diego 40

San Diego Avalon Outsource Development Newsletter 40

Xconomy

JULY 19, 2016

Synthorx, the San Diego synthetic biology startup that expanded the number of DNA base pairs with two synthetic nucleotides, said today it has raised $10 million in a Series B financing round led by RA Capital Management, the Boston life sciences hedge fund. coli bacteria and to make proteins that incorporate synthetic amino acids.

San Diego 40

San Diego Avalon Research Examples 40

Tech Zulu Event

DECEMBER 6, 2013

It’s something of a sci-fi fantasy scenario: Driverless cars that show up at the touch of a button. Auto-interfaces are clunky, and when a lot of these big tech companies IPO’d, a lot of them developed products that were endemic to the car industry – navigation, social graphs, etc.

Advertising 97

Advertising Startup Marketing Mobile 97

Xconomy

NOVEMBER 14, 2018

The San Diego-based company says it wants to use the proceeds to put its lead product candidate, an investigational cancer therapy that’s based on the drug interleukin-2 (IL-2), through dose escalation and expansion trials, and to develop products based on the same compound to treat autoimmune disorders.

San Diego 76

San Diego Product Develop Development 76